Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3028% below fair value
$0.52−0.02 (-3.82%)
Close on Nov 19, 2026Market cap $55.58MP/E –Yield –
Hyperfine shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Hyperfine's shares outstanding was 100M at Jun 30, 2026. For fiscal 2025 it was 82M, up 13.0% from the year before. The highest annual figure on record is 82M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 82M | +13.0% |
| FY2024 | Dec 31, 2024 | 72M | +1.5% |
| FY2023 | Dec 31, 2023 | 71M | +1.2% |
| FY2022 | Dec 31, 2022 | 70M | +1808.9% |
| FY2021 | Dec 31, 2021 | 4M | +142.3% |
| FY2020 | Dec 31, 2020 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 100M | +27.8% |
| Q1 FY2026 | Mar 31, 2026 | 98M | +29.1% |
| Q4 FY2025 | Dec 31, 2025 | 94M | +29.2% |
| Q3 FY2025 | Sep 30, 2025 | 79M | +8.7% |
| Q2 FY2025 | Jun 30, 2025 | 78M | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | 76M | +5.2% |
| Q4 FY2024 | Dec 31, 2024 | 73M | +1.8% |
| Q3 FY2024 | Sep 30, 2024 | 73M | +1.7% |
| Q2 FY2024 | Jun 30, 2024 | 72M | +1.2% |
| Q1 FY2024 | Mar 31, 2024 | 72M | +1.5% |
| Q4 FY2023 | Dec 31, 2023 | 72M | +1.6% |
| Q3 FY2023 | Sep 30, 2023 | 71M | +1.4% |
| Q2 FY2023 | Jun 30, 2023 | 71M | +1.2% |
| Q1 FY2023 | Mar 31, 2023 | 71M | +0.8% |
| Q4 FY2022 | Dec 31, 2022 | 71M | +3631.2% |
| Q3 FY2022 | Sep 30, 2022 | 71M | +4154.4% |
| Q2 FY2022 | Jun 30, 2022 | 70M | +4289.4% |
| Q1 FY2022 | Mar 31, 2022 | 70M | – |
| Q3 FY2021 | Sep 30, 2021 | 2M | – |
| Q2 FY2021 | Jun 30, 2021 | 2M | – |
| Q1 FY2021 | Mar 31, 2021 | 2M | – |
See a number that looks wrong?